Linerixibat | Interleukin Related interleukin-related.com

Product Name :
Linerixibat

Search keywords :
Linerixibat

drugId :
null

Target Vo:
Ileal bile acid transporter

Target Vo Short Name :
IBAT

Moa_Name:
Ileal bile acid transporter inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Glaxo Operations Uk Ltd

Active Indication_Name:
Cholestasis

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Argonaute 2 Antibody
GFP Antibody
Transferrin Antibody (YA840): Transferrin Antibody (YA840) is a non-conjugated and Mouse origined monoclonal antibody about 77 kDa. It can be used for WB,IHC-P,ICC/IF assays in the background of Human.

Author: Interleukin Related

Related Posts